Signaling via the T-cell antigen receptor heterodimer and the CD2 antigen: a novel, synergistic pathway for activation of T-cells.
Suthanthiran
M
M
Rogosin Institute, New York, New York.
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology*; D018801:CD2 Antigens; D006801:Humans; D008213:Lymphocyte Activation; D046911:Macromolecular Substances; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*; D011971:Receptors, Immunologic / Q000276:immunology*; D012016:Reference Values; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D018801:CD2 Antigens; D046911:Macromolecular Substances; D011948:Receptors, Antigen, T-Cell; D011971:Receptors, Immunologic